First Nebraska Trust’s Eli Lilly LLY Stock Holding History

First Nebraska Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.38M	Buy	6,933 +50	+0.7%	+$50.7K	0.59%	40
2025 Q4	$7.4M	Sell	6,883 -16	-0.2%	-$15.3K	0.68%	32
2025 Q3	$5.26M	Buy	6,899 +10	+0.1%	+$7.44K	0.48%	48
2025 Q2	$5.37M	Sell	6,889 -139	-2%	-$108K	0.51%	45
2025 Q1	$5.8M	Sell	7,028 -195	-3%	-$162K	0.57%	42
2024 Q4	$5.58M	Buy	7,223 +211	+3%	+$175K	0.54%	45
2024 Q3	$6.21M	Sell	7,012 -93	-1%	-$83.6K	0.6%	41
2024 Q2	$6.43M	Sell	7,105 -58	-0.8%	-$46.4K	0.66%	38
2024 Q1	$5.57M	Sell	7,163 -186	-3%	-$132K	0.58%	47
2023 Q4	$4.28M	Sell	7,349 -242	-3%	-$141K	0.49%	50
2023 Q3	$4.08M	Sell	7,591 -8	-0.1%	-$4.12K	0.51%	51
2023 Q2	$3.56M	Sell	7,599 -137	-2%	-$57.5K	0.43%	56
2023 Q1	$2.66M	Sell	7,736 -7,639	-50%	-$2.58M	0.33%	61
2022 Q4	$5.62M	Sell	15,375 -269	-2%	-$95.4K	0.73%	34
2022 Q3	$5.06M	Sell	15,644 -12,888	-45%	-$4.08M	0.72%	34
2022 Q2	$9.25M	Sell	28,532 -327	-1%	-$98.2K	1.21%	16
2022 Q1	$8.26M	Sell	28,859 -210	-0.7%	-$54K	0.98%	25
2021 Q4	$8.03M	Sell	29,069 -705	-2%	-$179K	0.97%	26
2021 Q3	$6.88M	Sell	29,774 -190	-0.6%	-$46.9K	0.9%	28
2021 Q2	$6.88M	Sell	29,964 -225	-0.7%	-$45.2K	0.9%	27
2021 Q1	$5.64M	Buy	30,189 +132	+0.4%	+$25.8K	0.76%	33
2020 Q4	$5.07M	Buy	30,057 +40	+0.1%	+$5.97K	0.73%	32
2020 Q3	$4.44M	Sell	30,017 -1,659	-5%	-$257K	0.76%	31
2020 Q2	$5.2M	Sell	31,676 -562	-2%	-$86.3K	0.96%	25
2020 Q1	$4.47M	Sell	32,238 -613	-2%	-$84.2K	0.98%	27
2019 Q4	$4.32M	Sell	32,851 -210	-0.6%	-$24.3K	0.7%	34
2019 Q3	$3.7M	Sell	33,061 -330	-1%	-$36.7K	0.61%	37
2019 Q2	$3.7M	Sell	33,391 -1,545	-4%	-$182K	0.65%	36
2019 Q1	$4.53M	Buy	34,936 +35	+0.1%	+$4.26K	0.82%	33
2018 Q4	$4.04M	Sell	34,901 -435	-1%	-$48.6K	0.82%	31
2018 Q3	$3.79M	Sell	35,336 -209	-0.6%	-$20.9K	0.64%	36
2018 Q2	$3.03M	Sell	35,545 -175	-0.5%	-$14.4K	0.65%	46
2018 Q1	$2.76M	Buy	35,720 +4,165	+13%	+$335K	0.55%	46
2017 Q4	$2.67M	Sell	31,555 -860	-3%	-$73.2K	0.55%	45
2017 Q3	$2.77M	Hold	32,415	–	–	0.61%	41
2017 Q2	$2.67M	Buy	32,415 +420	+1%	+$34.3K	0.6%	44
2017 Q1	$2.69M	Buy	31,995 +6,870	+27%	+$550K	0.6%	43
2016 Q4	$1.85M	Buy	25,125 +2,575	+11%	+$192K	0.44%	48
2016 Q3	$1.81M	Sell	22,550 -530	-2%	-$42.4K	0.47%	47
2016 Q2	$1.82M	Hold	23,080	–	–	0.47%	47
2016 Q1	$1.66M	Sell	23,080 -100	-0.4%	-$7.57K	0.46%	47
2015 Q4	$1.95M	Buy	23,180 +110	+0.5%	+$9.13K	0.59%	40
2015 Q3	$1.93M	Hold	23,070	–	–	0.61%	38
2015 Q2	$1.93M	Sell	23,070 -790	-3%	-$60.2K	0.59%	43
2015 Q1	$1.73M	Hold	23,860	–	–	0.51%	46
2014 Q4	$1.65M	Sell	23,860 -3,034	-11%	-$205K	0.48%	47
2014 Q3	$1.74M	Hold	26,894	–	–	0.5%	48
2014 Q2	$1.67M	Sell	26,894 -189	-0.7%	-$11.3K	0.48%	50
2014 Q1	$1.59M	Sell	27,083 -14,370	-35%	-$802K	0.49%	49
2013 Q4	$2.11M	Sell	41,453 -2,850	-6%	-$143K	0.66%	43
2013 Q3	$2.23M	Buy	+44,303	New	+$2.32M	0.77%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Nebraska Trust's LLY Position: Q1 2026 in Review

First Nebraska Trust increased its Eli Lilly (LLY) stake by 0.73% in Q1 2026, buying an estimated $50.7K and bringing the position to 6,933 shares worth $6.38M. The position accounts for 0.59% of the portfolio, ranked #40.

First Nebraska Trust first reported a position in LLY in Q3 2013 and has held it in 51 quarters since. The position peaked at $9.25M in Q2 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

First Nebraska Trust held 6,933 shares of Eli Lilly worth $6.38M as of Q1 2026.
First Nebraska Trust bought 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
Eli Lilly made up 0.59% of First Nebraska Trust's portfolio in Q1 2026, its #40 holding.
First Nebraska Trust first reported a position in Eli Lilly in Q3 2013 and has held it in 51 quarters since.
First Nebraska Trust's Eli Lilly position peaked at $9.25M in Q2 2022.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.